Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19
This public health model underscores the value of initiating remdesivir upon admission in patients hospitalized for COVID-19, in accordance with evidence-based best practices, to minimize lives lost because of severe acute respiratory syndrome coronavirus 2 infection.
Authors
- Mohsen Yaghoubi (ORCID: https://orcid.org/0000-0002-6912-7267)
- Martin Kolditz (ORCID: https://orcid.org/0000-0001-6022-6827)
- Sotirios Tsiodras (ORCID: https://orcid.org/0000-0002-0463-4321)
- Jakob J Malin (ORCID: https://orcid.org/0000-0002-2989-0436)
- Neera Ahuja (ORCID: https://orcid.org/0000-0002-2979-7530)
- Luke S. P. Moore (ORCID: https://orcid.org/0000-0001-7095-7922)
- Essy Mozaffari
- Roman Casciano (ORCID: https://orcid.org/0000-0002-7083-9536)
- André C. Kalil (ORCID: https://orcid.org/0000-0002-6489-6294)
- Aastha Chandak (ORCID: https://orcid.org/0000-0001-5653-435X)
- Ananth Kadambi (ORCID: https://orcid.org/0000-0002-5669-4887)
- Michele Bartoletti (ORCID: https://orcid.org/0000-0002-1099-3283)
Institutions
- Humanitas University (IT)
- University of Cologne (DE)
- National and Kapodistrian University of Athens (GR)
- Office of Infectious Diseases (US)
- Certara (United States) (US)
- Gilead Sciences (United States) (US)
- Certerra (United States) (US)
- University Hospital Cologne (DE)
- University Hospital Carl Gustav Carus (DE)
- IRCCS Humanitas Research Hospital (IT)
- Imperial College London (GB)
- University of Nebraska Medical Center (US)
- Technische Universität Dresden (DE)
- Stanford University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1093/cid/ciae517
- Citations
- 3
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.17